prednisolone has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 27 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
"Rowell syndrome is a rare distinctive entity first described in 1963 by Rowell and coworkers." | 2.44 | Rowell syndrome - case report and review of the literature. ( Azevedo, F; Baudrier, T; Duarte, AF; Mota, A; Pereira, M, 2008) |
"Rowell's syndrome is the name given to a distinct group of patients with lupus erythematosus who develop erythema multiforme-like lesions and have a characteristic serological picture." | 2.40 | Rowell's syndrome. ( Child, FJ; Creamer, D; Kapur, N; Kobza Black, A, 1999) |
"Lenalidomide was well tolerated." | 1.46 | Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus. ( Rabinovich, CE; Schanberg, LE; Wershba, EC; Wu, EY, 2017) |
"She was diagnosed as having systemic lupus erythematosus at the age of 21 years and had been receiving systemic steroid treatment (5 mg prednisolone/day)." | 1.32 | A case of nodular cutaneous lupus mucinosis. ( Furue, M; Koga, T; Moroi, Y; Terao, H; Urabe, K, 2003) |
"A case of acute disseminated encephalomyelitis (ADEM) preceding the features of cutaneous lupus is reported." | 1.30 | [Acute disseminated encephalomyelitis preceding cutaneous lupus]. ( Arfi, S; Cabre, P; Dubreuil, F; Quist, D; Smadja, D, 1998) |
"Treatment with prednisolone (15 mg/day), chloroquine phosphate (200 mg/ day), cyclosporine (5 mg/kg daily), and gold (10 mg/day) failed to reduce pruritic plaque formation, and pulse methylprednisolone therapy led to only a transient remission." | 1.29 | Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy. ( Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (29.63) | 18.2507 |
2000's | 7 (25.93) | 29.6817 |
2010's | 10 (37.04) | 24.3611 |
2020's | 2 (7.41) | 2.80 |
Authors | Studies |
---|---|
Ogawa-Momohara, M | 1 |
Muro, Y | 3 |
Goto, K | 1 |
Obuse, C | 1 |
Satoh, M | 1 |
Kono, M | 2 |
Akiyama, M | 3 |
Hoesly, PM | 1 |
Cappel, MA | 1 |
Hoesly, FJ | 1 |
Sluzevich, JC | 1 |
Tolaymat, LM | 1 |
Keeling, JH | 1 |
Chen, X | 1 |
Wang, S | 1 |
Li, L | 1 |
Ishiguro, Y | 1 |
Murase, C | 1 |
Takeichi, T | 1 |
Adachi, R | 1 |
Takahashi, K | 1 |
Wu, HHL | 1 |
White, A | 1 |
Bukhari, MAS | 1 |
Günther, C | 1 |
Hillebrand, M | 1 |
Brunk, J | 1 |
Lee-Kirsch, MA | 1 |
Sugiura, K | 1 |
Tanahashi, K | 1 |
Makino, T | 1 |
Seki, Y | 1 |
Hara, H | 1 |
Mizawa, M | 1 |
Matsui, K | 1 |
Shimizu, K | 1 |
Shimizu, T | 1 |
Scuderi, L | 1 |
Caltabiano, R | 1 |
Torrisi, GG | 1 |
Longo, V | 1 |
Pavone, A | 1 |
De Pasquale, R | 1 |
Banovic, F | 1 |
Olivry, T | 1 |
Linder, KE | 1 |
Tobias, JR | 1 |
Wu, EY | 1 |
Schanberg, LE | 1 |
Wershba, EC | 1 |
Rabinovich, CE | 1 |
Duarte, AF | 1 |
Mota, A | 1 |
Pereira, M | 1 |
Baudrier, T | 1 |
Azevedo, F | 1 |
Cisneros, CG | 1 |
Romiti, R | 1 |
Santi, CG | 1 |
Aoki, V | 1 |
Valente, NY | 1 |
Nico, MM | 1 |
Bohmeyer, J | 1 |
Achenbach, A | 1 |
Westenberger, M | 1 |
Stadler, R | 1 |
Terao, H | 1 |
Moroi, Y | 1 |
Urabe, K | 1 |
Koga, T | 1 |
Furue, M | 1 |
Lehmann, P | 1 |
Schrauwen, E | 1 |
Junius, G | 1 |
Swinnen, C | 1 |
Maenhout, T | 1 |
Sánchez-Pérez, J | 1 |
Gala, SP | 1 |
Jiménez, YD | 1 |
Fraga, J | 1 |
Diez, AG | 1 |
Vass, G | 1 |
Antal, Z | 1 |
Katona, M | 1 |
Kárpáti, S | 1 |
Balogh, L | 1 |
Matsumura, A | 1 |
Mitsumori, T | 1 |
Yoshida, T | 1 |
Akizuki, M | 1 |
Ishimaru, S | 1 |
Izaki, S | 1 |
Kitamura, K | 1 |
Morita, Y | 1 |
Stainforth, J | 1 |
Goodfield, MJ | 1 |
Taylor, PV | 1 |
Tsutsui, K | 1 |
Imai, T | 1 |
Hatta, N | 1 |
Sakai, H | 1 |
Takata, M | 1 |
Takehara, K | 1 |
Dubreuil, F | 1 |
Cabre, P | 1 |
Smadja, D | 1 |
Quist, D | 1 |
Arfi, S | 1 |
Child, FJ | 1 |
Kapur, N | 1 |
Creamer, D | 1 |
Kobza Black, A | 1 |
Wollina, U | 1 |
Looks, A | 1 |
Bouscarat, F | 1 |
Sellem, A | 1 |
Girardin, C | 1 |
Hoang, X | 1 |
Crickx, B | 1 |
de Prost, Y | 1 |
Belaïch, S | 1 |
5 reviews available for prednisolone and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
Rowell syndrome - case report and review of the literature.
Topics: Antibodies, Antinuclear; Erythema Multiforme; Female; Humans; Immunosuppressive Agents; Lupus Erythe | 2008 |
[Neonatal lupus erythematosus: case report and review of the literature].
Topics: Autoantibodies; Glucocorticoids; Humans; Infant, Newborn; Liver Function Tests; Lupus Erythematosus, | 2007 |
[Subacute cutaneous lupus erythematosus with positive anti SS-B antibody in the aged].
Topics: Aged; Antibodies, Antinuclear; Humans; Lupus Erythematosus, Cutaneous; Male; Prednisolone | 1994 |
Rowell's syndrome.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Erythema Multiforme; Femal | 1999 |
[Cutaneous sarcoidosis (lupus pernio) with neuroendocrine involvement].
Topics: Adult; Drug Resistance; Endocrine System Diseases; Facial Dermatoses; Humans; Lupus Erythematosus, C | 1991 |
22 other studies available for prednisolone and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Autoantibodies; Autoantigens; Facial Neoplasms | 2020 |
Leprosy as a Diagnostic Challenge in the United States.
Topics: Anti-Inflammatory Agents; Dermatitis; Female; Florida; Glucocorticoids; Humans; Lupus Erythematosus, | 2021 |
A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus.
Topics: Antirheumatic Agents; Dermis; Drug Administration Routes; Drug Therapy, Combination; Humans; Hydroxy | 2018 |
Drug-induced acute eosinophilic pneumonia due to hydroxychloroquine in a chilblain lupus patient.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Betamethasone; Chilblains; Drug Therapy, Comb | 2019 |
An atypical presentation of subacute cutaneous lupus erythematous.
Topics: Biopsy; Facial Dermatoses; Female; Glucocorticoids; Humans; Leg Dermatoses; Lupus Erythematosus, Cut | 2019 |
Systemic involvement in TREX1-associated familial chilblain lupus.
Topics: Chilblains; Exodeoxyribonucleases; Follow-Up Studies; Genetic Predisposition to Disease; Heterozygot | 2013 |
Cutaneous lupus mucinosis successfully treated with systemic corticosteroid and systemic tacrolimus combination therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Biopsy, Needle; Drug Therapy, Combination; F | 2013 |
Induction of skin lesions by ultraviolet B irradiation in a case of pemphigus erythematosus.
Topics: Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Cutaneous; Middl | 2014 |
Rowell syndrome.
Topics: Adult; Drug Therapy, Combination; Erythema Multiforme; Female; Humans; Hydroxychloroquine; Lupus Ery | 2015 |
Pathology in practice. Psoriasiform lichenoid dermatitis.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, C | 2014 |
Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus.
Topics: Adolescent; Female; Humans; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Cutaneous; Lupus | 2017 |
Toxic epidermal necrolysis-like cutaneous lupus erythematosus: A series of three patients.
Topics: Adolescent; Azathioprine; Chloroquine; Diagnosis, Differential; Drug Therapy, Combination; Female; H | 2010 |
[Thalidomide therapy of cutaneous lupus erythematosus].
Topics: Adult; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intrader | 2002 |
A case of nodular cutaneous lupus mucinosis.
Topics: Adult; Biopsy, Needle; Female; Humans; Immunohistochemistry; Lupus Erythematosus, Cutaneous; Lupus E | 2003 |
[Photodermatoses--case report].
Topics: Adult; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychlor | 2004 |
Dyschezia in dogs with discrete erosive anal disease and histological lesions suggestive of mucocutaneous lupus erythematosus.
Topics: Animals; Anus Diseases; Belgium; Constipation; Dog Diseases; Dogs; Female; Lupus Erythematosus, Cuta | 2004 |
Allergic contact dermatitis to prednicarbate presenting as lupus erythematosus.
Topics: Allergens; Cross Reactions; Dermatitis, Allergic Contact; Diagnosis, Differential; Facial Dermatoses | 2006 |
Neonatal lupus erythematosus: dissolution of atrioventricular block after administration of corticosteroid to the pregnant mother.
Topics: Female; Fetal Diseases; Heart Block; Humans; Infant; Lupus Erythematosus, Cutaneous; Prednisolone; P | 1994 |
Pregnancy-induced chilblain lupus erythematosus.
Topics: Adult; Chilblains; Female; Humans; Lupus Erythematosus, Cutaneous; Prednisolone; Pregnancy; Pregnanc | 1993 |
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3 | 1996 |
[Acute disseminated encephalomyelitis preceding cutaneous lupus].
Topics: Adult; Anti-Inflammatory Agents; Encephalomyelitis, Acute Disseminated; Female; Humans; Lupus Erythe | 1998 |
Extracorporeal photochemotherapy in cutaneous lupus erythematosus.
Topics: Adult; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Disco | 1999 |